This paper investigates the relationship between psychoactive substances and so-called paranormal phenomena falling within the study of parapsychology. It is primarily concerned with extrasensory perception (ESP)—telepathy, precognition, and clairvoyance—as well as out-of-body experiences (OBEs) and near-death experiences (NDEs). Psychokinesis (PK), aura vision, encounter experiences, and sleep paralysis only make a very limited contribution to this review as they are seldom related to psychoactive drugs within the parapsychological literature. It is organized into neurochemical models of paranormal experience (section 1), field reports of intentional and spontaneous phenomena incorporating anthropological, historical and clinical cases, and personal accounts (section 2), surveys of paranormal belief and experience (section 3), experimental research (section 4), and a methodological critique of the experimental research with recommendations for further work (section 5).
Read More“According to Dobkin de Rios and Rumrrill the psychedelic Amazonian jungle decoction, ayahuasca, has a history of continuous use spanning at least 8,000 years. After all that time non-indigenes are now developing an increasing interest in ayahuasca’s intriguing cultural, magico-religious, legal, medical and psychopharmacological dimensions. This book covers all of these aspects in varying degrees (less so the pharmacology), but is likely of most interest for its analysis of the brew’s use in shamanic and healing contexts. It is here too that the book has most to offer, with half its contents given over to anthropological insights into the native use of ayahuasca, including interviews over the course of some thirty years between the authors and several ayahuasqueros…”
Read More“In a recent article in this journal, Dos Santos et al. (2018) report a case of ayahuasca use by a man with aphantasia. This account is the first such report of the use of a psychedelic agent by someone with aphantasia. Surprisingly, the case, SE, reported an improvement in their visual imagery following one particular instance of ayahuasca use. In support of Dos Santos et al.’s (2018) favored psychological explanation for improvement and their suggestion that SE’s aphantasia was acquired rather than congenital, this letter reports on a case study of an individual with apparent congenital aphantasia who has experienced no visual imagery, despite reported having excessively smoked N,Ndimethyltryptamine. It is proposed that the theoretical distinction between acquired and congenital aphantasia be further explored with regard to the use of psychedelics…”
Read More